OTCMKTS:SEOVF Sernova Biotherapeutics Earnings Date & Estimates $0.07 0.00 (-2.40%) As of 11/20/2026 02:39 PM Eastern Sernova Biotherapeutics is estimated to report earnings on Thursday, December 17, 2026. Research:ProfileEarnings History Upcoming Earnings Announcement Announcement DateDecember 17, 2026 Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Sernova BiotherapeuticsSernova Biotherapeutics is expected to post earnings of -$0.0072 per share. In the same quarter a year earlier Sernova Biotherapeutics reported -$0.01 per share. Sernova Biotherapeutics last reported on September 10, 2026, posting -$0.01 per share and missing the -$0.0050 consensus estimate. Sernova Biotherapeutics has beaten the consensus EPS estimate in 1 of its last 4 quarters.Consensus EstimatesConsensus EPS-$0.0072Prior-Year EPS-$0.01Recent Track RecordLast ReportedQ3 2026Last Quarter EPS-$0.01 (Missed by -$0.0050)EPS Beat Rate1 of last 4 quartersPrepare for the Earnings CallEarnings HistoryCompany ProfileQ3 2026 Earnings ReportQ2 2026 Earnings ReportQ1 2026 Earnings Report Sernova Biotherapeutics Earnings FAQ When does Sernova Biotherapeutics report earnings? Sernova Biotherapeutics (OTCMKTS:SEOVF) is estimated to report earnings on Thursday, December 17, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Sernova Biotherapeutics? Analysts expect Sernova Biotherapeutics to post earnings of -$0.0072 per share for the quarter. Sernova Biotherapeutics Earnings HeadlinesSeraxis Names Former FDA Medical Officer Patricia Beaston As Chief Medical Officer Ahead Of MergerOctober 19, 2026 | rttnews.comSeraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova BiotherapeuticsOctober 19, 2026 | markets.businessinsider.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 21 at 1:00 AM | Profits Run (Ad)Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical TrialOctober 5, 2026 | globenewswire.comSernova Biotherapeutics Inc (SVA)September 25, 2026 | ca.investing.comSernova Biotherapeutics to Participate in Noble Capital Markets' Emerging Growth Virtual Equity ConferenceSeptember 25, 2026 | globenewswire.comSee More Sernova Biotherapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sernova Biotherapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sernova Biotherapeutics and other key companies, straight to your email. Email Address About Sernova BiotherapeuticsSernova Biotherapeutics (OTCMKTS:SEOVF) is a Canadian biotechnology company developing regenerative medicine technologies that use therapeutic cells to treat chronic diseases. Its primary platform, the Cell Pouch System, is an implantable device designed to support blood-vessel growth around transplanted cells. The company has focused on combining the Cell Pouch with insulin-producing islet cells as a potential treatment for type 1 diabetes. Its research has also included cell-based approaches for other conditions, such as thyroid disease and hemophilia. These programs are investigational, and the company’s technologies are not established treatments.View Sernova Biotherapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/16 - 11/20If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestHard Drives Were Left for Dead, But Seagate and Western Digital Are SoaringPalo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to RunGrand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts Outlook Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.